Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Mitchell
Article
The New Repair Network
Collision Repair Will Never Be the Same The repair network of today is not your grandfather’s or your father’s repair network; in fact it
Workers' Comp
Article
Impact of Drug Formularies on Workers' Compensation State Laws
Learn more about workers' compensation drug formularies and what impact states have seen on their drug utilization rates and costs. Inter
Workers' Comp
Article
Understanding Predictive Analytics For Workers' Compensation Data Analysis
As technology evolves, several key ideas continue to permeate our conversations.
Workers' Comp
News Release
Risk & Insurance: Treating Pain Without Drugs
From high praise to a spiraling crash, opioid-based pain medications are out of favor.
Mitchell
News Release
Arizona Senate Committee Gives Qualified Approval to SB 1111
The Arizona Senate Commerce and Public Safety Committee voted this week to recommend SB1111 on a 6-2 vote.
Workers' Comp
News Release
Stone Point Capital to Acquire Genex Services from Funds Advised by Apax Partners
Wayne, PA – Feb.